
ELMD Valuation
Electromed Inc
ELMD Relative Valuation
ELMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ELMD is overvalued; if below, it's undervalued.
Historical Valuation
Electromed Inc (ELMD) is now in the Fair zone, suggesting that its current forward PE ratio of 24.41 is considered Fairly compared with the five-year average of 30.11. The fair price of Electromed Inc (ELMD) is between 19.21 to 32.50 according to relative valuation methord.
Relative Value
Fair Zone
19.21-32.50
Current Price:24.17
Fair
24.41
PE
1Y
3Y
5Y
Trailing
Forward
11.68
EV/EBITDA
Electromed Inc. (ELMD) has a current EV/EBITDA of 11.68. The 5-year average EV/EBITDA is 16.45. The thresholds are as follows: Strongly Undervalued below 5.21, Undervalued between 5.21 and 10.83, Fairly Valued between 22.06 and 10.83, Overvalued between 22.06 and 27.68, and Strongly Overvalued above 27.68. The current Forward EV/EBITDA of 11.68 falls within the Historic Trend Line -Fairly Valued range.
17.07
EV/EBIT
Electromed Inc. (ELMD) has a current EV/EBIT of 17.07. The 5-year average EV/EBIT is 21.22. The thresholds are as follows: Strongly Undervalued below 10.54, Undervalued between 10.54 and 15.88, Fairly Valued between 26.55 and 15.88, Overvalued between 26.55 and 31.89, and Strongly Overvalued above 31.89. The current Forward EV/EBIT of 17.07 falls within the Historic Trend Line -Fairly Valued range.
24.17
PS
Electromed Inc. (ELMD) has a current PS of 24.17. The 5-year average PS is 2.53. The thresholds are as follows: Strongly Undervalued below -1.61, Undervalued between -1.61 and 0.46, Fairly Valued between 4.59 and 0.46, Overvalued between 4.59 and 6.66, and Strongly Overvalued above 6.66. The current Forward PS of 24.17 falls within the Strongly Overvalued range.
18.51
P/OCF
Electromed Inc. (ELMD) has a current P/OCF of 18.51. The 5-year average P/OCF is 1.02. The thresholds are as follows: Strongly Undervalued below -7.05, Undervalued between -7.05 and -3.01, Fairly Valued between 5.06 and -3.01, Overvalued between 5.06 and 9.10, and Strongly Overvalued above 9.10. The current Forward P/OCF of 18.51 falls within the Strongly Overvalued range.
20.38
P/FCF
Electromed Inc. (ELMD) has a current P/FCF of 20.38. The 5-year average P/FCF is 1.19. The thresholds are as follows: Strongly Undervalued below -8.20, Undervalued between -8.20 and -3.51, Fairly Valued between 5.88 and -3.51, Overvalued between 5.88 and 10.57, and Strongly Overvalued above 10.57. The current Forward P/FCF of 20.38 falls within the Strongly Overvalued range.
Electromed Inc (ELMD) has a current Price-to-Book (P/B) ratio of 4.67. Compared to its 3-year average P/B ratio of 3.50 , the current P/B ratio is approximately 33.38% higher. Relative to its 5-year average P/B ratio of 3.25, the current P/B ratio is about 43.72% higher. Electromed Inc (ELMD) has a Forward Free Cash Flow (FCF) yield of approximately 5.52%. Compared to its 3-year average FCF yield of 2.64%, the current FCF yield is approximately 108.61% lower. Relative to its 5-year average FCF yield of 2.09% , the current FCF yield is about 164.14% lower.
4.67
P/B
Median3y
3.50
Median5y
3.25
5.52
FCF Yield
Median3y
2.64
Median5y
2.09
Competitors Valuation Multiple
The average P/S ratio for ELMD's competitors is 15.50, providing a benchmark for relative valuation. Electromed Inc Corp (ELMD) exhibits a P/S ratio of 24.17, which is 55.93% above the industry average. Given its robust revenue growth of 17.27%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap

ELMD.A
Electromed Inc
24.17
Average P/S: 15.50
17.27%
202.45M

OSUR.O
OraSure Technologies Inc
2.40
-32.14%
171.80M

PMI.A
Picard Medical Inc
3.04
207.06%
224.05M

CATX.A
Perspective Therapeutics Inc
2.19
-44.87%
162.64M

OBIO.O
Orchestra Biomed Holdings Inc
3.81
7.46%
205.57M

UTMD.O
Utah Medical Products Inc
57.40
-4.30%
184.01M
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ELMD decreased by 21.47% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 14.83M to 17.39M.
The secondary factor is the Margin Expansion, contributed 2.84%to the performance.
Overall, the performance of ELMD in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch

AQST
Aquestive Therapeutics Inc
6.040
USD
-1.47%

DSGN
Design Therapeutics Inc
7.560
USD
+10.04%

RZLT
Rezolute Inc
10.760
USD
+12.08%

DOMO
Domo Inc
12.630
USD
+1.20%

AVIR
Atea Pharmaceuticals Inc
3.270
USD
+0.62%

SMTI
Sanara Medtech Inc
27.715
USD
-0.56%

ARQ
Arq Inc
3.850
USD
-6.10%

FPH
Five Point Holdings LLC
5.870
USD
+0.17%

BRBS
Blue Ridge Bankshares Inc
4.420
USD
-4.95%

RGP
Resources Connection Inc
4.470
USD
-1.97%
FAQ
Is Electromed Inc (ELMD) currently overvalued or undervalued?
Electromed Inc (ELMD) is now in the Fair zone, suggesting that its current forward PE ratio of 24.41 is considered Fairly compared with the five-year average of 30.11. The fair price of Electromed Inc (ELMD) is between 19.21 to 32.50 according to relative valuation methord.





